-BlueRiver Acquisition announced that it intends to transfer its listing from the New York Stock Exchange to the NYSE American. BlueRiver received written confirmation that it has been cleared to file an initial listing application with the NYSE American.
BlueRiver will voluntarily delist from the New York Stock Exchange, and anticipates the transfer to the NYSE American to occur by March 14.
BlueRiver’s decision to transfer to the NYSE American follows recent heavy redemptions of the SPAC’s Class A common stock in connection with the vote last month to extend its merger deadline until August. Based on the estimated redemption price of $10.63, the SPAC lost $284 million of the $292 million it held in trust.
BlueRiver in January said it had signed a non-binding letter of intent with a target in the medical technology sector, although no further announcements have been made regarding a deal. Read more.
